(Q34822131)

4 August 2017

1 reference

title

The effect of retinoids on premalignant oral lesions: focus on topical therapy (English)

1 reference

4 August 2017

Meir Gorsky

1

1 reference

PubMed ID

12216093

4 August 2017

Joel B Epstein

series ordinal

2

1 reference

PubMed ID

12216093

4 August 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

4 August 2017

1 reference

4 August 2017

95

1 reference

4 August 2017

1258-1264

1 reference

4 August 2017

6

1 reference

Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions

4 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Oral lichen planus: a benign lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Oral lichen planus: a potentially premalignant lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

A prospective study of findings and management in 214 patients with oral lichen planus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia: molecular evidence of incomplete resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Risk of preneoplastic and neoplastic events in operated oral leukoplakias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Biochemical treatment of precancerous oral lesions: The effectiveness of various analogues of retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Retinoid-sensitive cells and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Retinoids in cancer prevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Identification of a receptor for the morphogen retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

All-trans retinoic acid induced gene expression and growth inhibition in head and neck cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Transforming growth factor alpha (TGF-alpha) expression in dysplastic oral leukoplakia: modulation by 13-cis retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Differential effects of retinoic acid and N-(4-hydroxyphenyl)retinamide on head and neck squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Therapeutic effect of N-(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea-induced rat mammary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Roles of retinoids and their nuclear receptors in the development and prevention of upper aerodigestive tract cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

13-cis-retinoic acid in the treatment of oral leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Evaluation of chemoprevention of oral cancer with Spirulina fusiformis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Response of oral leukoplakias to the administration of vitamin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Vitamin A derivatives in the prevention and treatment of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Topical Tretinoin Therapy and Oral Lichen Planus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Prevalence study of oral white lesions with special reference to a new definition of oral leucoplakia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

Oral leukoplakia and malignant transformation. A follow-up study of 257 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

Studies in oral leukoplakia: A preliminary report on the period pervalence of malignant transformation in leukoplakia based on a follow-up study of 248 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

A prospective follow-up study of 570 patients with oral lichen planus: persistence, remission, and malignant association

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

Lichenoid dysplasia: a distinct histopathologic entity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

Oral cancer development in patients with oral lichen planus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

Molecular markers of the risk of oral cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.10874

1 reference

7 January 2021

Surgical treatment of premalignant lesions of the oral mucosa

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

Topical bleomycin for the treatment of dysplastic oral leukoplakia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

Topical application of vitamin A to oral leukoplakia: A clinical case series

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

Prevention of local relapses and new localisations of oral leukoplakias with the synthetic retinoid fenretinide (4-HPR). Preliminary results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

Biochemoprevention for dysplastic lesions of the upper aerodigestive tract

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

Initial experience in the treatment of oral leukoplakia with high-dose vitamin A and follow-up 5-aminolevulinic acid induced protoporphyrin IX fluorescence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

STUDIES IN ORAL LEUKOPLAKIAS. III. EFFECTS OF VITAMIN A COMPARING CLINICAL, HISTOPHATHOLOGIC, CYTOLOGIC, AND HEMATOLOGIC RESPONSES

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

The use of 13-cis-retinoic acid in the treatment of oral leukoplakia: short-term observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

Efficacy of etretinate (Tigason) in symptomatic oral lichen planus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

Topical application of isotretinoin gel improves oral lichen planus. A double-blind study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

Effect of retinoids on oral leukoplakia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

A modified classification and staging system for oral leukoplakia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10874

7 January 2021

Identifiers

DOI

10.1002/CNCR.10874

1 reference

4 August 2017

1 reference

PubMed ID

12216093